JEPHRYN LEE: Open Payments
NPI 1336800416 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,723 in 266 payments from 21 companies in 2025. Trend: 2023 $6,316 · 2024 $6,809 · 2025 $5,723
Food & beverage: $5,634Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 84 | $1,816 |
| GENZYME CORPORATION | 13 | $748 |
| UCB, Inc. | 45 | $518 |
| Novartis Pharmaceuticals Corporation | 14 | $425 |
| Incyte Corporation | 8 | $258 |
| LEO Pharma Inc. | 10 | $237 |
| Galderma Laboratories, L.P. | 17 | $215 |
| Amgen Inc. | 9 | $211 |
| Regeneron Healthcare Solutions, Inc. | 6 | $192 |
| Arcutis Biotherapeutics, Inc. | 13 | $189 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, Bimzelx, OPZELURA, OTEZLA, NEMLUVIO, Zoryve.
Industry payments across CA — which companies pay providers there.
